Staar Surgical Co (FRA:SR3) Cyclically Adjusted Revenue per Share: €4.26 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:SR3 Staar Surgical Co FRA:SR3
79 GF Score
Price €20.95
GF Value €27.71
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Staar Surgical Co Cyclically Adjusted Revenue per Share?

Staar Surgical Co FRA:SR3 +1.01% 79 Cyclically Adjusted Revenue per Share is €4.26 as of Mar. 2026. GuruFocus rates FRA:SR3 with a GF Score™ of 79/100 and a GF Value™ of €27.71 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Staar Surgical Co's adjusted revenue per share for the three months ended in Mar. 2026 was €1.589. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €4.26 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Staar Surgical Co's average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.60% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 14.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Staar Surgical Co was 17.40% per year. The lowest was -8.60% per year. And the median was 1.55% per year.

As of today (2026-08-02), Staar Surgical Co's current stock price is €20.95. Staar Surgical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €4.26. Staar Surgical Co's Cyclically Adjusted PS Ratio of today is 4.92.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Staar Surgical Co was 59.92. The lowest was 3.38. And the median was 12.67.


Staar Surgical Co  (FRA:SR3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Staar Surgical Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=20.95/4.26
=4.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Staar Surgical Co was 59.92. The lowest was 3.38. And the median was 12.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Staar Surgical Co Cyclically Adjusted Revenue per Share Related Terms


Staar Surgical Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Staar Surgical Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staar Surgical Co Cyclically Adjusted Revenue per Share Chart

Staar Surgical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.58 3.14 3.67 4.22 4.08

Staar Surgical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.19 3.94 4.02 4.08 4.26

FRA:SR3 vs KMTS, AZTA, BLFS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Staar Surgical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staar Surgical Co Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Staar Surgical Co's Cyclically Adjusted PS Ratio falls into.


FRA:SR3
79GF Score
Staar Surgical Co FRA:SR3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staar Surgical Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Staar Surgical Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.589/330.2130*330.2130
=1.589

Current CPI (Mar. 2026) = 330.2130.

Staar Surgical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.464 241.018 0.636
201609 0.441 241.428 0.603
201612 0.516 241.432 0.706
201703 0.467 243.801 0.633
201706 0.477 244.955 0.643
201709 0.468 246.819 0.626
201712 0.510 246.524 0.683
201803 0.510 249.554 0.675
201806 0.660 251.989 0.865
201809 0.592 252.439 0.774
201812 0.581 251.233 0.764
201903 0.615 254.202 0.799
201906 0.751 256.143 0.968
201909 0.757 256.759 0.974
201912 0.744 256.974 0.956
202003 0.708 258.115 0.906
202006 0.689 257.797 0.883
202009 0.830 260.280 1.053
202012 0.771 260.474 0.977
202103 0.866 264.877 1.080
202106 1.046 271.696 1.271
202109 1.000 274.310 1.204
202112 1.055 278.802 1.250
202203 1.164 287.504 1.337
202206 1.559 296.311 1.737
202209 1.550 296.808 1.724
202212 1.224 296.797 1.362
202303 1.387 301.836 1.517
202306 1.721 305.109 1.863
202309 1.524 307.789 1.635
202312 1.421 306.746 1.530
202403 1.455 312.332 1.538
202406 1.846 314.175 1.940
202409 1.605 315.301 1.681
202412 0.949 315.605 0.993
202503 0.798 319.799 0.824
202506 0.776 322.561 0.794
202509 1.597 324.800 1.624
202512 0.992 324.054 1.011
202603 1.589 330.213 1.589

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €4.26 mean?
Staar Surgical Co (FRA:SR3) has a Cyclically Adjusted Revenue per Share of €4.26 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Staar Surgical Co and its competitors.
Is Staar Surgical Co's Cyclically Adjusted Revenue per Share too high?
Staar Surgical Co's current Cyclically Adjusted Revenue per Share is €4.26. Overall, Staar Surgical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's Cyclically Adjusted Revenue per Share compare to KMTS and AZTA?
Staar Surgical Co's Cyclically Adjusted Revenue per Share of €4.26 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Staar Surgical Co and its competitors. Staar Surgical Co's current Cyclically Adjusted Revenue per Share is €4.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (FRA:SR3) is currently considered Modestly Undervalued. The stock's GF Value™ is €27.71, compared to a current price of €20.95 — trading 24.4% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €4.26. Staar Surgical Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Staar Surgical Co (FRA:SR3), the current Cyclically Adjusted Revenue per Share is €4.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staar Surgical Co (FRA:SR3) Overvalued in 2026?

Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued. The current stock price of €20.95 is trading 24.4% below its estimated GF Value™ of €27.71. GuruFocus considers Staar Surgical Co to be Modestly Undervalued.

Key valuation signals for FRA:SR3:

  • Cyclically Adjusted Revenue per Share: €4.26
  • GF Value™: €27.71 vs. price of €20.95 (24.4% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the FRA:SR3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staar Surgical Co Business Description

Other Exchanges STAA:USA
Address 25510 Commercentre Drive, Lake Forest, CA, USA, 92630
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score

Get the complete analysis for FRA:SR3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.95
Price
€27.71
GF Value